Your browser doesn't support javascript.
Letter to the Editor: Can the seasonal influenza vaccine for 2019/2020 have cross reactivity with some of the SARS-CoV-2 proteins?
Zandi, Milad; Behboudi, Emad; Soltani, Saber.
  • Zandi M; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Miladzandi416@gmail.com.
  • Behboudi E; Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Soltani S; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
Int J Infect Dis ; 110: 235-236, 2021 09.
Article in English | MEDLINE | ID: covidwho-1380661

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article